| NCT ID | NCT06052553 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Healthy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-09-09 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-09-09 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research is being done to investigate the novel neck strengthening device, TopSpin360 and its effectiveness on measures of neck strength and cognitive function.
Eligibility Criteria
Inclusion Criteria: * Fluent English Speaker. * Medically cleared to play ice hockey. Exclusion Criteria: * Clinically documented hearing issues. * In-ear hearing aid or cochlear implant. * Implanted pacemaker or defibrillator. * Metal or plastic implants in skull. lack of verbal fluency in the English language. * History of seizures. * Allergy to rubbing alcohol or EEG gel.
Contact & Investigator
Mario Hevesi, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT06052553 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 21 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06052553 currently recruiting?
Yes, NCT06052553 is actively recruiting participants. Contact the research team at Hawkins.Houston@mayo.edu for enrollment information.
Where is the NCT06052553 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT06052553 clinical trial?
NCT06052553 is sponsored by Mayo Clinic. The principal investigator is Mario Hevesi, MD at Mayo Clinic. The trial plans to enroll 60 participants.